ACG Updates Colorectal Cancer Guidlines|
Renown Health offers FIT home screenings, a preferred strategy for colon cancer detection
RENO, Nev. (April 28, 2009) – In connection with the American College of Gastroenterology’s (ACG) recently updated screening guidelines for colorectal cancer, Renown Health offers FIT (Fecal Immunochemical Test) home screenings for annual colon cancer detection.
In the March 2009 issue of “The American Journal of Gastroenterology,” ACG issued a report offering new graded recommendations for screening in an update of those published in 2000. The new guidelines revealed, in addition to recommending colonoscopy every 10 years starting at age 50 as the preferred test for cancer prevention, an annual FIT is the preferred strategy for colorectal cancer detection.
“This preferred strategy simplifies and shortens discussion with patients and should increase the likelihood that screenings are offered to patients,” said John Gray, M.D. FACG, of Gastroenterology Consultants. “It is impractical for a primary-care physician to discuss several different options for colorectal screening with each patient. People are busy, but they should consider taking the time for screenings not only for colorectal cancer but also a variety of other diseases."
Dr. Gray also said patients who have a family history of cancer should begin annual screenings ten years earlier than the age at which a family member was diagnosed. For example, if your father was diagnosed with cancer at 55, you should start annual screenings at 45.
The new ACG guidelines list FIT as a preferred strategy because it has more extensive data than the guaiac-based Hemoccult SENSA test, and because fecal DNA testing is expensive, the guidelines note.
According to the American Cancer Society, Nevada has one of the lowest compliance rates of colorectal cancer screenings. In 2004, only 36.7 percent of state residents over the age of 50 underwent screening, compared to 45.1 percent nationwide. Colon cancer has a 90 percent survival rate if caught early.
“With increased screening compliance, it is very possible to reduce cancer rates in the state,” Dr. Gray said.
Home Screening Kit – This screening detects cancers and polyps more successfully than older and more widely used stool-screening tests. Key patient benefits of the test include:
Higher sensitivity resulting in fewer false readings
More convenient for patients because it is easy to prepare and complete in the privacy of your own home
Only one sample required, as opposed to three consecutive samples with the previous guaiac tests
No dietary or medication restrictions required
FIT home screening kits are offered for just $35, with no physician referral required. To request a kit call 775-982-6830.
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 10,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive disease specialist through its emphasis on scholarly practice, teaching and research.
The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical, and cost-effective health care to gastroenterology patients. To learn more, visit www.acg.gi.org.
About Renown Institute for Cancer
Renown Institute for Cancer was the region’s first hospital recognized by the American College of Surgeons Commission on Cancer for comprehensive cancer care for more than 22 years. Only 25 percent of hospitals nationwide meet the Commission’s rigorous standards.
Renown Institute for Cancer is the largest healthcare provider in the area conducting clinical trials with the National Cancer Institute. Clinical trials allow patients to be on leading trends in medicine and often times they become involved in that "next big discovery" for cancer treatments. Leading northern Nevada in cancer research, Renown Institute for Cancer has administered more than 135 trials to 870 participants.
Whether individuals have been referred, are currently receiving treatment or are seeking a second opinion, they can make an appointment at Renown Institute for Cancer anytime. The team of skilled professionals brings expertise and comprehensive resources to patient care. For general inquiries, contact 775-982-6830 or visit www.renown.org.
Don Butterfield, Director of Communications, 775-690-4208
Daniel Davis, Public Relations Business Partner, 775-691-7308
Nicole Shearer , Public Relations Business Partner, 775-772-5191